Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

CALC

CalciMedica Inc

Apr 24 • 02:52PM ET

5.46

Dollar change +0.87
Percentage change 18.95	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-26.08	Insider Own	56.24%	Shs Outstand	5.75M	Perf Week	25.81%
Market Cap	58.64M	Forward P/E	-	EPS next Y	-1.40	Insider Trans	31.16%	Shs Float	4.70M	Perf Month	32.52%
Income	-34.36M	PEG	-	EPS next Q	-0.68	Inst Own	11.77%	Short Float	0.79%	Perf Quarter	-2.52%
Sales	0.00M	P/S	-	EPS this Y	70.30%	Inst Trans	1.58%	Short Ratio	1.66	Perf Half Y	195.14%
Book/sh	1.42	P/B	3.85	EPS next Y	38.46%	ROA	-132.51%	Short Interest	0.04M	Perf Year	60.12%
Cash/sh	1.05	P/C	5.22	EPS next 5Y	-	ROE	-155.72%	52W Range	1.75 - 8.59	Perf YTD	90.91%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.56%	ROI	-421.20%	52W High	-36.44%	Beta	1.47
Dividend TTM	-	Quick Ratio	2.88	Sales past 5Y	0.00%	Gross Margin	-	52W Low	212.00%	ATR (14)	0.42
Dividend Ex-Date	-	Current Ratio	2.88	EPS Y/Y TTM	-12.44%	Oper. Margin	0.00%	RSI (14)	72.28	Volatility	6.23% 6.85%
Employees	14	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	16.38
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	84.94%	Payout	-	Rel Volume	2.07	Prev Close	4.59
Sales Surprise	-	EPS Surprise	17.48%	Sales Q/Q	-	Earnings	Mar 28 BMO	Avg Volume	22.43K	Price	5.46
SMA20	28.10%	SMA50	25.18%	SMA200	50.16%	Trades		Volume	38,819	Change	18.95%

Today 08:00AM	CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (PR Newswire) +18.95%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-28-24 11:53AM	CALC Stock Earnings: CalciMedica Reported Results for Q4 2023 (InvestorPlace)
07:00AM	CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-13-24 08:00AM	CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
06:57PM	Loading…
Feb-28-24 06:57PM	CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-13-24 08:00AM	CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury (PR Newswire) -8.21%
Feb-07-24 04:05PM	CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +6.92%
Jan-22-24 08:00AM	CalciMedica Announces Private Placement of up to Approximately $55 Million (PR Newswire) +7.09%
Dec-11-23 07:30AM	CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition (PR Newswire) -13.88%
Nov-09-23 07:00AM	CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -12.74%
Nov-02-23 09:15AM	CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition (PR Newswire) +10.23%
Sep-06-23 07:30AM	CalciMedica Announces Upcoming Presentations and Events in September (PR Newswire) +5.18%
Aug-31-23 07:30AM	CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 (PR Newswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
04:05PM	Loading…
Aug-10-23 04:05PM	CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 07:30AM	CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP) (GlobeNewswire) +6.06%
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research) -6.29%
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research) -6.11%
07:12AM	Loading…
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research) -5.56%
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.16%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research) +7.08%
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research) +13.07%
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research) -17.32%
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research) +11.75%
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research) +28.00%
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research)
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) -6.76%
Jun-12-23 07:30AM	CalciMedica Announces Relisting on Nasdaq (GlobeNewswire)
Jun-06-23 07:30AM	CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP) (GlobeNewswire) +16.85%
May-23-23 07:30AM	CalciMedica Expands Executive Team with New Appointments (GlobeNewswire) +9.49%
May-15-23 08:55AM	CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
Mar-29-23 07:53PM	Charts Point to Higher Highs, Says Oppenheimer. Heres a Stock With Over 100% Upside Potential (TipRanks) -8.76%

CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Roberts Eric W	CHIEF BUSINESS OFFICER	Apr 02 '24	Buy	3.90	3,254	12,691	39,894	Apr 02 08:33 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Apr 01 '24	Buy	3.90	746	2,909	36,640	Apr 02 08:33 PM
MIDDLETON FRED A	Director	Jan 23 '24	Buy	3.70	679,384	2,515,080	946,744	Jan 25 08:00 PM
Sanderling Venture Partners VI	10% Owner	Jan 23 '24	Buy	3.70	436,028	1,614,176	727,433	Jan 25 08:00 PM
Sanderling Venture Partners VI	10% Owner	Jan 23 '24	Buy	3.70	243,356	900,904	946,744	Jan 25 08:00 PM
WILSON ROBERT N	Director	Dec 11 '23	Buy	3.30	506	1,670	182,161	Dec 13 08:45 PM
Leheny A. Rachel	Chief Executive Officer	Nov 07 '23	Buy	3.34	2,000	6,680	18,840	Nov 08 08:42 PM
Leheny A. Rachel	Chief Executive Officer	Nov 06 '23	Buy	3.12	2,440	7,615	16,840	Nov 07 06:09 PM
Roberts Eric W	Chief Business Officer	Nov 06 '23	Buy	3.12	2,400	7,488	35,894	Nov 08 08:41 PM
Hebbar Sudarshan	Chief Medical Officer	Nov 03 '23	Buy	2.74	36,000	98,600	46,000	Nov 07 06:08 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.83	11,249	31,846	33,494	Nov 07 08:42 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.70	5,860	15,828	22,245	Nov 06 06:40 PM
Leheny A. Rachel	Chief Executive Officer	Nov 03 '23	Buy	2.85	5,000	14,250	14,400	Nov 06 06:39 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.77	3,700	10,249	20,287	Nov 07 08:42 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.80	3,200	8,960	16,587	Nov 06 06:40 PM
Roberts Eric W	Chief Business Officer	Aug 25 '23	Buy	3.18	736	2,340	5,000	Aug 29 07:34 PM
Roberts Eric W	Chief Business Officer	Aug 22 '23	Buy	3.27	714	2,335	4,264	Aug 23 06:02 PM
Roberts Eric W	Chief Business Officer	Aug 21 '23	Buy	3.25	1,750	5,688	3,550	Aug 23 06:02 PM
Roberts Eric W	Chief Business Officer	Jun 26 '23	Buy	3.70	1,200	4,441	13,387	Jun 26 08:33 PM
Roberts Eric W	Chief Business Officer	Jun 26 '23	Buy	3.53	200	706	16,385	Jun 26 08:33 PM
Roberts Eric W	Chief Business Officer	Jun 23 '23	Buy	3.35	500	1,675	16,185	Jun 26 08:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CALC

CalciMedica Inc

Upgrade your FINVIZ experience